Dietary rice bran attenuates hepatic stellate cell activation and liver fibrosis in mice through enhancing antioxidant ability
Fang-Yu Hsu,Suh-Ching Yang,Fat-Moon Suk,Hitoshi Shirakawa,Wan-Chun Chiu,Yi-Jen Liao
DOI: https://doi.org/10.1016/j.jnutbio.2023.109565
IF: 6.117
2024-01-05
The Journal of Nutritional Biochemistry
Abstract:Various endogenous and exogenous stimuli can result in an inflammatory response and collagen deposition in the liver, which affect liver function and increase the risk of developing liver cirrhosis and cancer. Rice bran, the main byproduct of rice milling, contains various nutrients which possess hepatoprotective activities. In this study, we investigated the effects of rice bran on carbon tetrachloride (CCl 4 )-induced liver fibrosis in mice. Mice were fed a rice-bran-containing diet (10% rice bran w/w) or a standard diet with or without an injection of 20% CCl 4 to induce liver fibrosis. Our results showed that feeding a rice-bran-containing diet could alleviate CCl 4 -induced liver damage, collagen deposition, and expressions of fibrosis-related genes, including α-smooth muscle actin ( α-SMA ), collagen 1a2 ( COL1A2 ), and transforming growth factor-β ( TGF-β ) in liver tissues. Moreover, consumption of rice bran enhanced phase II detoxification and antioxidant gene expressions, including Gsta3, Gstp1 , C atalase, SOD1, SOD2 , and SOD3 . Treatment with γ-oryzanol, the major bioactive compound in rice bran, decreased the sensitivity of hepatic stellate cells (HSCs) to TGF-β1-induced α-SMA, COL1A2 , and phosphorylated smad2 expressions. In conclusion, a rice-bran-containing diet may have beneficial effects on liver fibrogenesis through increased antioxidant and detoxification activities. γ-Oryzanol, the major bioactive compound of rice bran, can inhibit activation of HSCs.
biochemistry & molecular biology,nutrition & dietetics